Allakos Inc (STU:37Z)
€ 1.1655 0.081 (7.47%) Market Cap: 106.17 Mil Enterprise Value: 28.93 Mil PE Ratio: 0 PB Ratio: 1.37 GF Score: 28/100

Allakos Inc. - Special Call Transcript

Aug 05, 2019 / 12:00PM GMT
Release Date Price: €27.35 (-0.83%)
Operator

Greetings. Welcome to Allakos Corporate Update Call. (Operator Instructions) As a reminder, this conference is being recorded.

I will now turn the conference over to Mr. Robert Alexander, CEO. Mr. Alexander, you may now begin your presentation.

Robert Alexander
Allakos Inc. - CEO & Director

All right. Thank you. I'd like to thank everybody for joining the call. We're obviously very excited about the data we released this morning and we'll get to it momentarily.

I want to remind everybody that we will be making forward-looking statements. So please refer to our SEC filings for a discussion of our risk factors.

Today in the room with me, I'm joined by Dr. Adam Tomasi, our President and COO; Dr. Henrik Rasmussen, our Chief Medical Officer, and we're fortunate to have one of our principal investigators and key opinion leaders in the field of EGIDs, Dr. Evan Dellon, who is at the University of North Carolina Chapel Hill. And he'll be joining us to give his perspective on the data a bit later.

In terms of the agenda today,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot